Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer.
Sophie E VollenbrockF E M VonckenJ M van DierenD M J LambregtsM MaasG J MeijerLucas GoenseS MookK J HarteminkP SnaebjornssonL C Ter BeekM VerheijB M P AlemanR G H Beets-TanA Bartels-RuttenPublished in: The British journal of surgery (2019)
Preoperative assessment of residual tumour on MRI after nCRT for oesophageal cancer is feasible with high sensitivity, reflecting a low chance of missing residual tumour. However, the specificity was low; this results in overstaging of complete responders as having residual tumour and, consequently, overtreatment.